Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase 2 study of Nitric Oxide Releasing Solution for the inactivation of SARs-CoV-2, the virus that causes COVID-19

Next Previous
Search
Trial Profile

A phase 2 study of Nitric Oxide Releasing Solution for the inactivation of SARs-CoV-2, the virus that causes COVID-19

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 26 May 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Nitric oxide (Primary)
  • Indications COVID 2019 infections
  • Focus Therapeutic Use

    • Most Recent Events

    • 26 May 2020 New trial record
    • 25 May 2020 According to a SaNOtize Research and Development Corporation media release, first patient in the trial was enrolled on 12 May 2020. The Company is continuing enrolment in British Columbia and will initiate enrolment in Quebec on June 1.
    • 25 May 2020 Status changed from planning to recruiting, according to a SaNOtize Research and Development Corporation media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top